Live Markets
Wednesday, July 29, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Financial Services

Innovation1 Biotech Inc. (IVBT)

PNK · Shell Companies

$0.000.00 (0.00%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$4,494
P/E (TTM)
EPS
$-0.31
Div Yield
52W Range
$0.00–$0.00
Beta
15.45

Company overview

Innovation1 Biotech Inc. focuses on researching, developing, producing, and selling pharmaceutical products. The company offers natural supplements for the treatment of symptoms associated with the flu and long covid under the NutraFlu and Nutravid19 brands; and other supplement and medical nutrition products. It also develops NLC001 that is in Phase II clinical trial for the treatment of long covid and other viral indications. The company is based in New York, New York.

Peers in Financial Services

Innovation1 Biotech Inc. has no peer companies in this window.

Recent press releases

Innovation1 Biotech Inc. has not issued a press release in this window.

SEC filings

All filings →

Innovation1 Biotech Inc. has not filed an SEC document in this window.

Innovation1 Biotech Inc. has no reported insider trades in the last 90 days.

Institutional holders

All holders →

No 13F holdings have been reported for Innovation1 Biotech Inc. in this window.

People at Innovation1 Biotech Inc.

All people →

Quarterly financials

Full financials →

No quarterly financials have been ingested for Innovation1 Biotech Inc..

IVBT (PNK) Stock Quote, Press Releases & SEC... | Cayman Journal | Cayman Journal